NCT00129623View on ClinicalTrials.gov

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Post-Menopausal Osteopenia

Interventions

DRUG

Placebo

po monthly for 1 year

DRUG

ibandronate [Bonviva/Boniva]

150mg po monthly for 1 year

Trial Locations (12)

20817

Bethesda

23294

Richmond

23502

Norfolk

34996

Stuart

45224

Cincinnati

48236

Detroit

63110

St Louis

68131

Omaha

79124

Amarillo

80227

Lakewood

87106

Albuquerque

97213

Portland

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00129623 - A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia | Biotech Hunter | Biotech Hunter